Lumiracoxib
Lumiracoxib (Prexige) is a highly selective COX-2 inhibitor, demonstrating potent activity with an IC50 of 0.14 μM and over 500-fold selectivity versus COX-1. This compound has been utilized in research models to investigate inflammation, pain pathways, and cardiovascular effects in both cellular and animal studies.
Product Specifications
CAS Number
220991-20-8
Product Name Alternative
Prexige, bone cancer, Cyclooxygenase, COX, COX 189, COX-1, COX189, COX-189, COX-2, Lumiracoxib, Metabolic Syndrome, osteoarthritis, inflammatory, inhibit, Inhibitor, hyperalgesic
Field of Research
Immunology & Inflammation, Neuroscience, Pharmacology & Drug Discovery
Purity
96.64% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:55 mg/mL (187.25 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.81 mM)
Smiles
N (C1=C (CC (O) =O) C=C (C) C=C1) C2=C (Cl) C=CC=C2F
Molecular Formula
C15H13ClFNO2
Molecular Weight
293.72
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS965888-01 0.02 mg (E-Coli)
Recombinant Dog Calsequestrin-2 (CASQ2)
Sign In for Pricing
View Details MBS965888-02 0.02 mg (Yeast)
Recombinant Dog Calsequestrin-2 (CASQ2)
Sign In for Pricing
View Details MBS965888-03 0.1 mg (E-Coli)
Recombinant Dog Calsequestrin-2 (CASQ2)
Sign In for Pricing
View Details MBS965888-04 0.1 mg (Yeast)
Recombinant Dog Calsequestrin-2 (CASQ2)
Sign In for Pricing
View Details MBS965888-05 0.02 mg (Baculovirus)
Recombinant Dog Calsequestrin-2 (CASQ2)
Sign In for Pricing
View Details MBS965888-06 0.02 mg (Mammalian-Cell)
Recombinant Dog Calsequestrin-2 (CASQ2)
Sign In for Pricing
View Details